|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1990-4-20
|
|
pubmed:abstractText |
Mean ratings of positive and negative symptoms and depression significantly improved in nine treatment-resistant schizophrenic patients who completed a 6-week open trial of fluoxetine added to their neuroleptics. The authors identify differences between responders and nonresponders and recommend controlled trials.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
147
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
492-4
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1969245-Adult,
pubmed-meshheading:1969245-Antipsychotic Agents,
pubmed-meshheading:1969245-Clinical Trials as Topic,
pubmed-meshheading:1969245-Depression,
pubmed-meshheading:1969245-Drug Therapy, Combination,
pubmed-meshheading:1969245-Female,
pubmed-meshheading:1969245-Fluoxetine,
pubmed-meshheading:1969245-Humans,
pubmed-meshheading:1969245-Male,
pubmed-meshheading:1969245-Pilot Projects,
pubmed-meshheading:1969245-Schizophrenia,
pubmed-meshheading:1969245-Schizophrenic Psychology
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.
|
|
pubmed:affiliation |
Erich Lindemann Mental Health Center, Massachusetts General Hospital, Boston.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
